Pharma

BBVA share price at 6,393 euros How is the Spanish Ibex 35 index doing? Pharma Mar under pressure… Grifols, Pharma Mar and BBVA bring Ibex 35 to the brink! Grifols leaves the center of the target… BBVA leaves us if

photo freepik.com Today is Sunday, March 19, 2023. We start a new week in the month of March by analyzing the latest trends what is happening in the Spanish index, Ibex 35, which is leaving the Mediterranean stock market chaotic with its actions. Those that are part of the Ibex 35 are Acciona, Acerinox, ACS …

BBVA share price at 6,393 euros How is the Spanish Ibex 35 index doing? Pharma Mar under pressure… Grifols, Pharma Mar and BBVA bring Ibex 35 to the brink! Grifols leaves the center of the target… BBVA leaves us if Read More »

Contaminated eye drops in US cause death and blindness in several people: They could have drug-resistant bacteria

At least 68 people in the United States have been infected eye infection through contaminated droplets, which caused the death of three people, it left eight people blind and four required surgery to remove one eye. Health authorities in the United States reported that the cause of this situation was the use of eye drops …

Contaminated eye drops in US cause death and blindness in several people: They could have drug-resistant bacteria Read More »

The prices of the “pharmacy” industry in Spain will begin to increase by 2.9% in 2023

Production costs in the pharmaceutical industry will begin in March 2023. Sector Industrial Price Index (Ipri) Pharmacy The latest data published this Friday by the National Institute of Statistics (INE) shows that in January 2023 it increased by 2.9% year-on-year. The January data is higher than the December 2022 record when the pharmaceutical industry Ipri …

The prices of the “pharmacy” industry in Spain will begin to increase by 2.9% in 2023 Read More »

Face Pharma expects profit to grow by 8.6% in 2022 to €89.5 million

Face Pharma will increase your profits. The Spanish laboratory closed 2022 with a profit of 89.5 million eurosThis translates into an 8.6% increase compared to 2021 results, the group reported in a statement sent to the National Securities Market Commission (Cnmv) this Tuesday. The pharmaceutical company In 2022, payment of 462 million euros, an increase …

Face Pharma expects profit to grow by 8.6% in 2022 to €89.5 million Read More »

Spanish ‘pharmacy’ to grow profits by 16.4% in 2022, up to 560 million euros

The Spanish pharmaceutical sector returns, again, to gain muscle. Spanish companies listed in the sector In 2022 compared to 2021, they increased their collective net profit by 16.4% to more than 500 million euros. Pharmacy and collected by PlantaDoce. Grifols, Almiral, Rovi, Rig Joffre, Face Pharma and Pharma Mar have a combined profit of 558.9 …

Spanish ‘pharmacy’ to grow profits by 16.4% in 2022, up to 560 million euros Read More »

Face Pharma offers practical meetings for pharmaceutical professionals in Infarma

Face Pharma will participate in a series of meetings with pharmaceutical professionals at the European pharmacy meeting Inpharma Barcelona 2023 at Fira de Barcelona from March 14 to 16 at stand number D61. Pharmaceutical care shares… Face Pharma will participate in a series of meetings with pharmaceutical professionals at the European pharmacy meeting Inpharma Barcelona …

Face Pharma offers practical meetings for pharmaceutical professionals in Infarma Read More »

The production of “pharmacy” in Spain will begin to grow again by 19.7% in 2023.

Drug production in Spain continues to increase. In the year In January 2023, the Industrial Production Index (IPI) of the pharmaceutical sector recorded a year-on-year increase of 19.7%, according to the latest data published this Tuesday by the National Institute of Statistics (INE). Although revised again, the data for January 2023 is six percent lower …

The production of “pharmacy” in Spain will begin to grow again by 19.7% in 2023. Read More »

Bayer’s new leadership gives wings to supporters of the change in strategy

New director, new strategy? In June, Bayer will undergo a transfer of power longed by its investors and recommended by analysts: Werner Baumann, who has 35 years of experience at the German company, will hand over the baton. For former Roche Pharmaceutical Director Bill Anderson. Foreign consolidation with a pharmaceutical profile was well received, even …

Bayer’s new leadership gives wings to supporters of the change in strategy Read More »

Letizia Pharmacy Anti-Hair Loss Shampoo is the best in 50: Sulphate-free dosage

If you suffer from hair loss, it will not be surprising if you soon see how it increases. Time and season changes You can go further. Without forgetting Other reasons Factors that can affect the decline, such as the passage of time, stress, restrictive diets, hormonal changes, use of certain medications or not. Proper care …

Letizia Pharmacy Anti-Hair Loss Shampoo is the best in 50: Sulphate-free dosage Read More »

Scroll to Top